Imagine this: You need a life-saving cancer drug. In China, it costs just $280. In the U.S.? $8,892. Same drug. Same dose. So, what’s going on?
A Tale of Two Price Tags
The drug in question is Toripalimab (Loqtorzi), a PD-1 inhibitor developed by China’s Junshi Biosciences.…